| |
|
|
|
|
|
|
|||
|
Blood, 1 June 2004, Vol. 103, No. 11, pp. 4302-4309. Prepublished online as a Blood First Edition Paper on February 19, 2004; DOI 10.1182/blood-2003-01-0107.
Submitted January 14, 2003
Pediatrics, Yale University, New Haven, CT, USA * Corresponding author; email: patrick.gallagher{at}yale.edu.
The majority of K-Cl cotransport in the erythrocyte is attributed to KCC1. K-Cl cotransport is elevated in sickle erythrocytes and the KCC1 gene has been proposed as a modifier gene in sickle cell disease. To provide insight into our understanding of the regulation of the human KCC1 gene, we mapped the 5' end of the KCC1 cDNA, cloned the corresponding genomic DNA, and identified the KCC1 gene promoter. The core promoter lacks a TATA-box and is composed of an initiator element (InR) and a downstream promoter element (DPE), a combination found primarily in Drosophila gene promoters and rarely observed in mammalian gene promoters. Mutational analyses demonstrated that both the InR and DPE sites were critical for full promoter activity. In vitro DNAse I foot printing, electrophoretic mobility shift assays, and reporter gene assays identified functional AP-2- and Sp1 sites in this region. The KCC1 promoter was transactivated by forced expression of AP-2 in heterologous cells. Sequences encoding the InR, DPE, AP-2 and Sp1 sites were 100% conserved between human and murine KCC1 genes. In vivo studies using chromatin immunoprecipitation assays with anti-histone H3 and anti-histone H4 antibodies demonstrated hyperacetylation of this core promoter region.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2004 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||